Dextromethorphan is an N-methyl-D-aspartate (NMDA) receptor antagonist
which has been shown to inhibit the development of cutaneous secondar
y hyperalgesia after tissue trauma. We studied 60 ASA I-II patients un
dergoing total abdominal hysterectomy in a randomized, double-blind, p
lacebo-controlled study. Patients received either dextromethorphan 27
mg capsules, two doses before operation and three doses in the first 2
4 h after operation, or placebo. Visual analogue pain scores (VAS) at
24 and 48 h were assessed at rest, on coughing and on sitting up, and
were not significantly different between groups. Morphine consumption
from a patient-controlled analgesia (PCA) device was also not signific
antly different between groups. Evidence of secondary hyperalgesia was
assessed with von Prey hairs 10 cm above the Pfannenstiel incision. B
oth groups of patients exhibited evidence of secondary hyperalgesia af
ter 24 and 48 h but there were no significant differences between grou
ps. There was also no difference between groups in VAS scores at 1 mon
th.